Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Ampicillin	O
/	O
Penicillins	O
/	O
Percocet	O
/	O
Bactrim	O
/	O
Gold	O
Salts	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Nose	O
bleed	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Blood	O
transfusion	O
History	O
of	O
Present	O
Illness:	O
HPI:	O
___	O
hx	O
of	O
RA,	O
OA,	O
pulmonary	O
artery	O
hypertension,	O
chronic	O
pulmonary	O
embolism	O
on	O
lovenox	O
and	O
a	O
new	O
diagnosis	O
of	O
myelofibrosis	O
presented	O
to	O
the	O
ED	O
with	O
epistaxis	O
and	O
is	O
admitted	O
for	O
monitoring.	O
She	O
was	O
recently	O
admitted	O
___	O
to	O
___	O
for	O
anemia	O
thought	O
secondary	O
to	O
new	O
diagnosis	O
of	O
myelofibrosis	O
vs	O
myelofibrosis	O
with	O
myelodysplasia,	O
vs	O
spent	O
phase	O
polycythemia	O
___	O
on	O
bone	O
marrow	O
biopsy.	O
She	O
was	O
also	O
started	O
on	O
Lovenox	O
for	O
chronic	O
Pulmonary	O
emboli	O
and	O
doxycycline	O
for	O
left	O
lower	O
extremity	O
cellulitis.	O
This	O
morning	O
she	O
had	O
about	O
45	O
minute	O
oozing	O
nose-bleed	O
after	O
she	O
picked	O
her	O
nose.	O
HCT	O
was	O
checked	O
and	O
found	O
to	O
be	O
24.1	O
there	O
was	O
no	O
report	O
of	O
respiratory	O
distress	O
or	O
hemodynamic	O
instability,	O
she	O
was	O
referred	O
to	O
the	O
ED	O
for	O
a	O
transfusion.	O
On	O
arrival	O
to	O
the	O
ED,	O
vitals	O
were	O
Vital	O
Signs:	O
Pulse:	O
78,	O
RR:	O
18,	O
BP:	O
150/71,	O
O2Sat:	O
99,	O
O2Flow:	O
4L.	O
Epistaxis	O
had	O
resolved	O
and	O
whs	O
was	O
without	O
complaints.	O
Exam	O
showed	O
continued	O
erythemia	O
at	O
the	O
right	O
lower	O
extremity	O
at	O
the	O
site	O
of	O
cellulitis.	O
Labs	O
showed	O
Hgb	O
8.5/HCT	O
26.4	O
(previously	O
HGB	O
9.1/HCT	O
28.4)	O
WBC	O
10.5	O
Platelet	O
1380	O
(1173	O
prviously)	O
INR	O
1.5.	O
She	O
was	O
given	O
vancomycin	O
1g	O
IV	O
admitted	O
for	O
a	O
transfusion	O
and	O
apparent	O
RLE	O
cellulitis	O
that	O
has	O
not	O
responded	O
to	O
PO	O
antibiotics.	O
Vitals	O
on	O
transfer	O
78,	O
150/71,	O
18,	O
99%	O
4L	O
NC	O
On	O
arrival	O
to	O
the	O
floor,	O
vitals	O
T:	O
98.3	O
BP:	O
150/84	O
P:80	O
RR	O
16	O
SaO2	O
98%	O
2LNC	O
she	O
reports	O
epistaxis	O
has	O
not	O
returned,	O
and	O
states	O
that	O
her	O
left	O
lower	O
extremity	O
is	O
overall	O
improved	O
since	O
discharge	O
previously.	O
She	O
complains	O
of	O
itching	O
at	O
her	O
lower	O
back.	O
Review	O
of	O
systems:	O
(+)	O
Per	O
HPI	O
(-)	O
Denies	O
fever,	O
chills,	O
night	O
sweats.	O
Denies	O
headache,	O
sinus	O
tenderness,	O
rhinorrhea	O
or	O
congestion.	O
Denied	O
cough,chest	O
pain	O
or	O
tightness,	O
palpitations.	O
Denied	O
vomiting,	O
diarrhea,	O
constipation	B-Constipation
or	O
abdominal	O
pain.	O
No	O
recent	O
change	O
in	O
bowel	O
or	O
bladder	O
habits.	O
No	O
dysuria.	O
Past	O
Medical	O
History:	O
1.	O
Seropositive	O
nonerosive	O
rheumatoid	O
arthritis	O
2.	O
SIADH	O
of	O
unclear	O
etiology	O
(___)	O
3.	O
Chronic	O
venous	O
insufficiency	O
4.	O
Osteopenia	O
w/	O
L2-L3	O
compression	O
fracture	O
5.	O
HTN	O
6.	O
Deafness	B-Hearing_impairment
7.	O
Depression	O
8.	O
Arthritis	O
9.	O
Obesity	O
10.	O
Urinary	B-Urinary_incontinence
Incontinence	B-Urinary_incontinence
11.	O
HL	O
12.	O
wet	O
macular	B-Visual_impairment
degeneration	B-Visual_impairment
13.	O
BCC	O
on	O
nasal	O
bridge	O
s/p	O
excision	O
in	O
___	O
Social	O
History:	O
___	O
Family	O
History:	O
Noncontributory	O
Physical	O
Exam:	O
Admission	O
Vitals:	O
T:	O
98.3	O
BP:	O
150/84	O
P:80	O
RR	O
16	O
SaO2	O
98%	O
2LNC	O
General:	O
Elderly	O
female	O
very	O
hard	O
of	O
hearing	O
Pleasant	O
and	O
in	O
NAD	O
HEENT:	O
Crusted	O
blood	O
at	O
anterior	O
nares	O
bilaterally,	O
No	O
blood	O
in	O
the	O
oral	O
pharynx	O
Neck:	O
supple,	O
no	O
LAD	O
Lungs:	O
CTAB	O
no	O
wheezes/rales/ronchi	O
CV:	O
RRR,	O
normal	O
S1	O
+	O
S2,	O
no	O
murmurs,	O
rubs,	O
gallops	O
Abdomen:	O
soft,	O
non-tender,	O
non-distended,	O
no	O
rebound	O
tenderness	O
or	O
guarding	O
Ext:	O
Left	O
lower	O
extremity	O
shows	O
dry	O
scaling	O
skin	O
with	O
an	O
area	O
of	O
ill	O
defined	O
erythema	O
extending	O
beyone	O
the	O
markings	O
made	O
in	O
the	O
ED,	O
warmer	O
than	O
the	O
right	O
lower	O
extremity	O
with	O
non	O
pitting	O
edema.	O
RLE	O
without	O
erythemia.	O
2+	O
pulses.	O
Discharge:	O
Vitals:	O
T:	O
98.3	O
BP:	O
150/84	O
P:80	O
RR	O
16	O
SaO2	O
98%	O
2LNC	O
General:	O
Elderly	O
female	O
very	O
hard	O
of	O
hearing	O
Pleasant	O
and	O
in	O
NAD	O
HEENT:	O
Crusted	O
blood	O
at	O
anterior	O
nares	O
bilaterally,	O
No	O
blood	O
in	O
the	O
oral	O
pharynx	O
Neck:	O
supple,	O
no	O
LAD	O
Lungs:	O
CTAB	O
no	O
wheezes/rales/ronchi	O
CV:	O
RRR,	O
normal	O
S1	O
+	O
S2,	O
no	O
murmurs,	O
rubs,	O
gallops	O
Abdomen:	O
soft,	O
non-tender,	O
non-distended,	O
no	O
rebound	O
tenderness	O
or	O
guarding	O
Ext:	O
Left	O
lower	O
extremity	O
shows	O
dry	O
scaling	O
skin	O
with	O
an	O
area	O
of	O
ill	O
defined	O
erythema	O
extending	O
beyone	O
the	O
markings	O
made	O
in	O
the	O
ED,	O
warmer	O
than	O
the	O
right	O
lower	O
extremity	O
with	O
non	O
pitting	O
edema.	O
RLE	O
without	O
erythema.	O
Bruise	O
on	O
right	O
medial	O
leg.	O
Marked	O
stable	O
nontender	O
to	O
palpation.	O
2+	O
pulses.	O
Discharge:	O
Pertinent	O
Results:	O
___	O
06:15AM	O
BLOOD	O
WBC-8.9	O
RBC-3.11*	O
Hgb-9.2*	O
Hct-28.6*	O
MCV-92	O
MCH-29.6	O
MCHC-32.2	O
RDW-16.9*	O
Plt	O
___	O
___	O
06:35AM	O
BLOOD	O
WBC-8.4	O
RBC-2.53*	O
Hgb-7.7*	O
Hct-24.2*	O
MCV-96	O
MCH-30.3	O
MCHC-31.8	O
RDW-17.4*	O
Plt	O
___	O
___	O
05:50PM	O
BLOOD	O
Neuts-62	O
Bands-2	O
___	O
Monos-3	O
Eos-7*	O
Baso-0	O
___	O
Myelos-0	O
___	O
06:35AM	O
BLOOD	O
Glucose-80	O
UreaN-17	O
Creat-0.7	O
Na-134	O
K-5.0	O
Cl-99	O
HCO3-27	O
AnGap-13	O
Imaging:	O
None	O
Micro:	O
None	O
Pending:	O
Blood	O
cultures.	O
Brief	O
Hospital	O
Course:	O
___	O
with	O
multiple	O
DVT's,	O
PE's	O
currently	O
on	O
lovenox,	O
recently	O
diagnosed	O
with	O
myelodysplastic	O
syndrome	O
who	O
presents	O
in	O
the	O
setting	O
of	O
a	O
resolved	O
mild	O
nose	O
bleed	O
and	O
anemia	O
for	O
which	O
she	O
was	O
transfused	O
two	O
units.	O
#MDS	O
___	O
has	O
recently	O
been	O
diagnosed	O
with	O
MDS.	O
___	O
has	O
a	O
very	O
high	O
platelet	O
count	O
with	O
concomitant	O
severe	O
macrocytic	O
anemia.	O
She	O
is	O
now	O
blood	O
transfusion	O
dependent.	O
This	O
was	O
diagnosed	O
upon	O
her	O
last	O
hospital	O
visit.	O
While	O
she	O
was	O
at	O
her	O
___	O
facility,	O
the	O
___	O
reports	O
"picking	O
her	O
nose"	O
which	O
resulted	O
in	O
a	O
slow	O
nose	O
bleed	O
which	O
lasted	O
approximately	O
45	O
minutes.	O
Per	O
the	O
___,	O
the	O
bleed	O
was	O
very	O
slow	O
and	O
not	O
large	O
in	O
volume.	O
By	O
the	O
time	O
she	O
had	O
arrived	O
at	O
the	O
emergency	O
department,	O
her	O
bleed	O
had	O
stopped.	O
However,	O
her	O
hematocrit	O
was	O
24.	O
She	O
was	O
transfused	O
two	O
units	O
of	O
RBCs	O
with	O
an	O
appropriate	O
increase	O
in	O
HCT.	O
#Anticoagulation:	O
Secondary	O
to	O
the	O
___	O
blood	O
dyscrasia	O
which	O
puts	O
her	O
at	O
risk	O
for	O
clots,	O
she	O
was	O
continued	O
on	O
lovenox	O
and	O
aspirin	O
per	O
recommendations	O
of	O
heme-onc.	O
On	O
her	O
follow	O
up	O
appointment	O
with	O
heme/onc,	O
discussion	O
regarding	O
possible	O
transition	O
to	O
warfarin	O
will	O
be	O
discussed.	O
#Hypoxemia:	O
This	O
was	O
stable	O
during	O
this	O
admission	O
and	O
the	O
___	O
remained	O
on	O
her	O
home	O
oxygen	O
which	O
was	O
started	O
on	O
previous	O
admission.	O
She	O
is	O
___	O
on	O
1L	O
NC	O
at	O
rest.	O
#Cellulitis:	O
The	O
___	O
has	O
a	O
mild	O
case	O
of	O
left	O
lower	O
extremity	O
cellulitis	O
which	O
is	O
being	O
treated	O
with	O
a	O
total	O
10	O
day	O
course	O
of	O
doxycycline.	O
Of	O
note,	O
the	O
area	O
has	O
not	O
increased	O
in	O
size,	O
redness,	O
or	O
warmth.	O
It	O
is	O
slowly	O
resolving.	O
Code	O
Status:	O
After	O
discussion	O
with	O
her	O
PCP,	O
___,	O
the	O
___	O
was	O
made	O
DNR/DNI.	O
Transitional	O
issues:	O
1.	O
Anticoagulation:	O
Until	O
a	O
new	O
plan	O
is	O
established	O
with	O
her	O
hematologists	O
the	O
___	O
will	O
remain	O
on	O
lovenox	O
80mg	O
sq	O
BID	O
and	O
aspirin	O
81mg	O
qd	O
for	O
VTE	O
ppx.	O
2.	O
Your	O
facility	O
will	O
be	O
contacted	O
by	O
hematology	O
in	O
order	O
for	O
the	O
___	O
to	O
establish	O
follow	O
up	O
with	O
heme-onc	O
at	O
___	O
to	O
arrange	O
for	O
the	O
___	O
to	O
receive	O
blood	O
transfusions	O
in	O
the	O
outpatient	O
setting	O
if	O
clinically	O
indicated.	O
3.	O
CBC	O
draws	O
QoD	O
and	O
fax	O
results	O
to	O
Office	O
___,	O
MD	O
___	O
Medications	O
on	O
Admission:	O
1.	O
enoxaparin	O
80	O
mg/0.8	O
mL	O
Syringe	O
Sig:	O
Eighty	O
(80)	O
mg	O
Subcutaneous	O
Q12H	O
(every	O
12	O
hours).	O
2.	O
aspirin	O
81	O
mg	O
Tablet,	O
Chewable	O
Sig:	O
One	O
(1)	O
Tablet,	O
Chewable	O
PO	O
DAILY	O
(Daily).	O
3.	O
valsartan	O
160	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
4.	O
doxycycline	O
hyclate	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
Q12H	O
(every	O
12	O
hours)	O
for	O
4	O
days.	O
5.	O
simvastatin	O
10	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
6.	O
citalopram	O
20	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
7.	O
folic	O
acid	O
1	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
8.	O
Xanax	O
0.25	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
at	O
bedtime.	O
9.	O
dorzolamide-timolol	O
___	O
%	O
Drops	O
Sig:	O
One	O
(1)	O
Drop	O
Ophthalmic	O
BID	O
(2	O
times	O
a	O
day).	O
10.	O
acetaminophen	O
325	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
TID	O
(3	O
times	O
a	O
day)	O
as	O
needed	O
for	O
pain.	O
11.	O
calcitonin	O
(salmon)	O
200	O
unit/actuation	O
Spray,	O
Non-Aerosol	O
Sig:	O
One	O
(1)	O
spray	O
Nasal	O
DAILY	O
(Daily).	O
12.	O
brimonidine	O
0.15	O
%	O
Drops	O
Sig:	O
One	O
(1)	O
Drop	O
Ophthalmic	O
BID	O
(2	O
times	O
a	O
day).	O
13.	O
triamcinolone	O
acetonide	O
0.1	O
%	O
Ointment	O
Sig:	O
One	O
(1)	O
Appl	O
Topical	O
TID	O
(3	O
times	O
a	O
day)	O
as	O
needed	O
for	O
itching.	O
14.	O
Calcium	O
500	O
+	O
D	O
500	O
mg(1,250mg)	O
-400	O
unit	O
Tablet	O
Sig:	O
___	O
Tablets	O
PO	O
twice	O
a	O
day.	O
Discharge	O
Medications:	O
1.	O
enoxaparin	O
80	O
mg/0.8	O
mL	O
Syringe	O
Sig:	O
Eighty	O
(80)	O
mg	O
Subcutaneous	O
Q12H	O
(every	O
12	O
hours).	O
2.	O
aspirin	O
81	O
mg	O
Tablet,	O
Chewable	O
Sig:	O
One	O
(1)	O
Tablet,	O
Chewable	O
PO	O
DAILY	O
(Daily).	O
3.	O
valsartan	O
160	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
4.	O
doxycycline	O
hyclate	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
Q12H	O
(every	O
12	O
hours)	O
for	O
4	O
days.	O
5.	O
simvastatin	O
10	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
6.	O
citalopram	O
20	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
7.	O
folic	O
acid	O
1	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
8.	O
Xanax	O
0.25	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
at	O
bedtime.	O
9.	O
dorzolamide-timolol	O
___	O
%	O
Drops	O
Sig:	O
One	O
(1)	O
Drop	O
Ophthalmic	O
BID	O
(2	O
times	O
a	O
day).	O
10.	O
acetaminophen	O
325	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
TID	O
(3	O
times	O
a	O
day)	O
as	O
needed	O
for	O
pain.	O
11.	O
calcitonin	O
(salmon)	O
200	O
unit/actuation	O
Spray,	O
Non-Aerosol	O
Sig:	O
One	O
(1)	O
spray	O
Nasal	O
DAILY	O
(Daily).	O
12.	O
brimonidine	O
0.15	O
%	O
Drops	O
Sig:	O
One	O
(1)	O
Drop	O
Ophthalmic	O
BID	O
(2	O
times	O
a	O
day).	O
13.	O
triamcinolone	O
acetonide	O
0.1	O
%	O
Ointment	O
Sig:	O
One	O
(1)	O
Appl	O
Topical	O
TID	O
(3	O
times	O
a	O
day)	O
as	O
needed	O
for	O
itching.	O
14.	O
Calcium	O
500	O
+	O
D	O
500	O
mg(1,250mg)	O
-400	O
unit	O
Tablet	O
Sig:	O
___	O
Tablets	O
PO	O
twice	O
a	O
day.	O
15.	O
Outpatient	O
Lab	O
Work	O
CBC	O
every	O
48	O
hours.	O
Please	O
call	O
results	O
into	O
the	O
office	O
of	O
___	O
___,	O
MD	O
___	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
1.	O
Myelodysplastic	O
Syndrome	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Out	O
of	O
Bed	O
with	O
assistance	B-Bed_Chairbound
to	O
chair	B-Bed_Chairbound
or	O
wheelchair.	B-Mobile_with_aid
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
with	O
anemia	O
which	O
means	O
you	O
have	O
a	O
low	O
level	O
of	O
blood.	O
You	O
also	O
have	O
too	O
many	O
platelets	O
which	O
has	O
been	O
causing	O
you	O
blood	O
clots.	O
This	O
is	O
because	O
you	O
have	O
an	O
abnormality	O
in	O
your	O
bone	O
marrow	O
(the	O
area	O
where	O
blood	O
is	O
made).	O
Since	O
your	O
bone	O
marrow	O
does	O
not	O
properly	O
make	O
blood,	O
you	O
will	O
require	O
blood	O
transfusions	O
going	O
forward	O
which	O
you	O
will	O
be	O
able	O
to	O
get	O
as	O
an	O
outpatient.	O
However,	O
this	O
will	O
need	O
to	O
arranged	O
through	O
the	O
hematologists	O
at	O
___.	O
They	O
will	O
be	O
in	O
contact	O
with	O
you.	O
You	O
still	O
have	O
some	O
residual	O
left	O
lower	O
leg	O
cellulitis.	O
It	O
is	O
very	O
mild.	O
We	O
will	O
continue	O
to	O
treat	O
you	O
with	O
5	O
more	O
days	O
of	O
an	O
antibiotic	O
called	O
doxycycline.	O
Continue:	O
Doxycycline	O
100mg	O
twice	O
a	O
day	O
for	O
4	O
days.	O
If	O
you	O
experience	O
any	O
of	O
the	O
danger	O
symptoms	O
as	O
listed	O
below	O
please	O
talk	O
to	O
the	O
physicians	O
on	O
staff	O
at	O
your	O
facility	O
and	O
consider	O
coming	O
back	O
to	O
the	O
___	O
emergency	O
department.	O
Followup	O
Instructions:	O
___	O

